Clinical Trial Update: A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial TS-172 for hyperphosphatemia in patients on hemodialysis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• TS-172

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Hyperphosphatemia Patients on Hemodialysis | Phase 3 | Status: NOT_YET_RECRUITING